Literature DB >> 15584769

Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Michael Poyurovsky1, Abraham Weizman, Ronit Weizman.   

Abstract

There is a considerable overlap of schizophrenia and obsessive-compulsive disorder (OCD) in the structural and functional brain abnormalities involved, role of the dopamine/serotonin neurotransmitter systems, and some demographic and clinical characteristics. Although OCD co-occurs in a substantial proportion of schizophrenia patients, a systematic evaluation of the clinical features and treatment of this population is lacking. This review critically evaluates findings of recent studies pertaining to the rate of occurrence of OCD or obsessive-compulsive symptoms (OCS) in schizophrenia and the clinical characterisation of the schizo-obsessive subtype. Specifically, interrelationships between obsessive-compulsive and schizophrenic symptoms in terms of temporal relationships and their association with specific schizophrenia subtypes and the effect of OCS on the severity of schizophrenia symptoms are addressed. In the absence of evidence-based data, tentative therapeutic approaches in this difficult-to-treat patient subgroup are suggested. These include monotherapy with atypical antipsychotic agents or a combination of either typical or atypical antipsychotics with SSRIs or clomipramine. The clinical characteristics of antipsychotic-induced OCS/OCD are also presented to facilitate identification and management of this rare but clinically significant adverse effect. Finally, future directions of research in schizophrenia-OCD comorbidity relevant to clinical practice are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15584769     DOI: 10.2165/00023210-200418140-00004

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  110 in total

1.  Improvement of obsessions and compulsions with clozapine in an individual with schizophrenia.

Authors:  P Tibbo; K Gendemann
Journal:  Can J Psychiatry       Date:  1999-12       Impact factor: 4.356

2.  Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder.

Authors:  Frits Jonkers; Lieuwe De Haan
Journal:  Psychopharmacology (Berl)       Date:  2002-04-04       Impact factor: 4.530

3.  Intravenous clomipramine for a schizophrenic patient with obsessive-compulsive symptoms.

Authors:  M Poyurovsky; A Weizman
Journal:  Am J Psychiatry       Date:  1998-07       Impact factor: 18.112

4.  A case report of risperidone-induced obsessive-compulsive symptoms.

Authors:  K Alzaid; B D Jones
Journal:  J Clin Psychopharmacol       Date:  1997-02       Impact factor: 3.153

5.  Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.

Authors:  R W Baker; D Ames; D S Umbricht; K N Chengappa; N R Schooler
Journal:  Psychopharmacol Bull       Date:  1996

6.  Obsessive-compulsive symptoms and clozapine.

Authors:  P F Buckley; S C Schulz
Journal:  Br J Psychiatry       Date:  1994-09       Impact factor: 9.319

7.  Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis.

Authors:  T R Insel; H S Akiskal
Journal:  Am J Psychiatry       Date:  1986-12       Impact factor: 18.112

8.  Schizophrenia: lifetime co-morbidity in a community sample.

Authors:  R C Bland; S C Newman; H Orn
Journal:  Acta Psychiatr Scand       Date:  1987-04       Impact factor: 6.392

9.  Obsessive compulsive disorder with psychotic features.

Authors:  J L Eisen; S A Rasmussen
Journal:  J Clin Psychiatry       Date:  1993-10       Impact factor: 4.384

10.  The prognostic significance of obsessive-compulsive symptoms in schizophrenia.

Authors:  W S Fenton; T H McGlashan
Journal:  Am J Psychiatry       Date:  1986-04       Impact factor: 18.112

View more
  26 in total

1.  Ziprasidone for obsessive compulsive disorder in schizophrenia.

Authors:  Daniela L Krause; Judith Matz; Rebecca Schennach; Norbert Müller; Sandra Dehning
Journal:  Ther Adv Psychopharmacol       Date:  2013-04

2.  Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.

Authors:  Frederike Schirmbeck; Daniela Mier; Christine Esslinger; Franziska Rausch; Susanne Englisch; Sarah Eifler; Andreas Meyer-Lindenberg; Peter Kirsch; Mathias Zink
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

Review 3.  Anxiety in Patients with Schizophrenia: Epidemiology and Management.

Authors:  Henk Temmingh; Dan J Stein
Journal:  CNS Drugs       Date:  2015       Impact factor: 5.749

4.  Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.

Authors:  Carolyn I Rodriguez; Cheryl Corcoran; Helen Blair Simpson
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

5.  Nonclinical obsessive-compulsive symptoms and executive functions in schizophrenia.

Authors:  Sheba R Kumbhani; Robert M Roth; Carrie L Kruck; Laura A Flashman; Thomas W McAllister
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

Review 6.  Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature.

Authors:  Chloé Tezenas du Montcel; Antoine Pelissolo; Franck Schürhoff; Baptiste Pignon
Journal:  Curr Psychiatry Rep       Date:  2019-07-01       Impact factor: 5.285

7.  Treatment of anxiety from musical obsessions with a cognitive behaviour therapy tool.

Authors:  Lassi A Liikkanen; Kari Raaska
Journal:  BMJ Case Rep       Date:  2013-11-08

Review 8.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

9.  Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder.

Authors:  Myung-Ji Lee; Yong-Bum Shin; Young-Kyung Sunwoo; Seung-Ho Jung; Won-Hyoung Kim; Min-Hee Kang; Jeong-Seop Lee; Jae-Nam Bae; Chul-Eung Kim
Journal:  Psychiatry Investig       Date:  2009-11-09       Impact factor: 2.505

10.  Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophrenia.

Authors:  Ganesan Venkatasubramanian; Naren P Rao; Rishikesh V Behere
Journal:  Indian J Psychol Med       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.